Herombopag + rhTPO in Severe Immune Thrombocytopenia

Clinical trial NCT05328804 · UNKNOWN

Trial details

NCT number: NCT05328804
Sponsor: Yin Jie
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Immune Thrombocytopenia

Start date: 2022-01-01
Primary completion: 2023-11-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.